Epidemiological Studies of Microvascular and Macrovasacular Complications in Diabetes Mellitus Type
DOI:
https://doi.org/10.52783/jns.v14.3451Keywords:
Diabetic retinopathy, Diabetic neuropathy, Diabetic nephropathy, Peripheral artery disease, coronary artery disease, Ischemic strokeAbstract
Aim: To perform an observational study on epidemiology of micro and macrovascular complications in diabetes mellitus type II.
Objectives: To assess the occurrence and prevalence of micro and macrovascular complications in type 2 diabetes mellitus.
Methodology: The study's methodology will be carried out in the internal medicine department of Gleneagles Aware Hospital in Bairamalguda, Saroornagar, Hyderabad, Telangana state. Over 6 month period with 100 patients individuals with microvascular problems. Patients aged 20 to 80 years, included with comorbid conditions in both genders. Patient demographics, medication records, laboratory tests, medical histories, and other relevant data were gathered using a well-designed data-collecting form for any in patients with diabetes mellitus who were experiencing problems.
Results: The study findings revealed that most of the complications that occur in diabetic mellitus are macrovascular complications. Out of 100 subjects, 65 were males and 35 were female, 70 had macrovascular complications. In 70, (2) peripheral artery disease, (29) coronary artery disease, (39) ischemic stroke. And 30 are microvascular complications, (1) diabetic retinopathy, (4) diabetic neuropathy, (25) diabetic nephropathy. The age group between 61-70 (36) was found to have the most macrovascular and microvascular complications.
Conclusion: The study concluded among 100 patients, who are affected by micro vascular and macrovascular complications in type 2 diabetes mellitus, are studied during the study period
Downloads
Metrics
References
Joseph T. Dipiro , Gary C. Yee, L.Michael posey stuart T. Haines, Thomas D.Nolin, Vicki Ellingsod. chapter no 91 diabetic mellitus, Editors: Joseph T. Dipiro, gary c.yee, L.michael posey, Stuart T.Haines, Thomas D. Nolin, Vicki L. Ellingrod , Pharmacotherapy a pathophysiologic Approach 11thedition p.3570.
Joseph T. Dipiro , Gary C. Yee, L.Michael posey stuart T. Haines, Thomas D.Nolin, Vicki Ellingsod. chapter no 91 diabetic mellitus, Editors: Joseph T. Dipiro, gary c.yee, L.michael posey, Stuart T.Haines, Thomas D. Nolin, Vicki L. Ellingrod , Pharmacotherapy a pathophysiologic Approach 11th edition p.3574.
Joseph T. Dipiro , Robert L.Talbert , Gary C. Yee, Gary R. Matzke, Barbara G. Wells, Michael Posey, chapter no:83 Diabetic Mellitus, editors: Joseph T. Dipiro , Robert L.Talbert , Gary C. Yee, Gary R. Matzke, Barbara G. Wells, Michael Posey, Pharmacotherapy A pathophysiological Approach 8th edition p.1256.
Loscalzo, Fauci, Kasper, Hauser, Longo, jameson chapter no 405, Diabetes Mellitus: Complications, Editors: Joseph Loscalzo, Dennis L. Kasper, Dan L. Longo, Anthony S. Fauci, Stephen L. Hauser, J. Larry Jameson, Harrison's Principles of Internal medicine 21st edition p.3120.
Loscalzo, Fauci, Kasper, Hauser, Longo, jameson chapter no 405, Diabetes Mellitus: Complications, Editors: Joseph Loscalzo, Dennis L. Kasper, Dan L. Longo, Anthony S. Fauci, Stephen L. Hauser, J. Larry Jameson, Harrison's Principles of Internal medicine 21st edition p.3121.
Loscalzo, Fauci, Kasper, Hauser, Longo, jameson chapter no 405, Diabetes Mellitus: Complications, Editors: Joseph Loscalzo, Dennis L. Kasper, Dan L. Longo, Anthony S. Fauci, Stephen L. Hauser, J. Larry Jameson, Harrison's Principles of Internal medicine 21st edition p.3122.
Schreur V, van Asten F, Ng H, Weeda J, Groenewoud JMM, Tack CJ, Hoyng CB, de Jong EK, Klaver CCW, Jeroen Klevering B. Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus. Acta Ophthalmol. 2018 Aug;96(5):459-464.
Loscalzo, Fauci, Kasper, Hauser, Longo, jameson chapter no 405, Diabetes Mellitus: Complications, Editors: Joseph Loscalzo, Dennis L. Kasper, Dan L. Longo, Anthony S. Fauci, Stephen L. Hauser, J. Larry Jameson, Harrison's Principles of Internal medicine 21st edition p.3124.
Medically reviewed by Deborah Weatherspoon, Ph.D., MSN-Written by Tom Seymour Updated on January 19, 2022.
Cate Whittlesea, Karen Hodson. Chapter 45, diabetic mellitus. Editor: Cate Whittlesea, Karen Hodson, Clinical Pharmacy and Therapeutics,6thEdition (2019). P. 772.
Stuart H.Ralston, Ian D. Penman, mark W.J. Strachan, Richard P.Hobson, Chapter no:16, Diabetes mellitus, Editors: Stuart H.Ralston, Ian D. Penman, mark W.J. Strachan, Richard P.Hobson, Davidson’s principles and practice of medicine 24thEdition p. 484.
Cate Whittlesea, Karen Hodson. Chapter 20, coronary artery disease. Editor: Cate Whittlesea, Karen Hodson, Clinical Pharmacy and Therapeutics,6thEdition (2019). P. 335.
Cate Whittlesea, Karen Hodson. Chapter 20, coronary artery disease. Editor: Cate Whittlesea, Karen Hodson, Clinical Pharmacy and Therapeutics,6thEdition (2019). P. 338.
Joseph T. Dipiro , Gary C. Yee, L.Michael posey stuart T. Haines, Thomas D.Nolin, Vicki Ellingsod. chapter no 27 Stroke, Editors: Joseph T. Dipiro, gary c.yee, L.michael posey, Stuart T.Haines, Thomas D. Nolin, Vicki L. Ellingrod , Pharmacotherapy a pathophysiologic Approach 11thedition p.353
Joseph T. Dipiro , Gary C. Yee, L.Michael posey stuart T. Haines, Thomas D.Nolin, Vicki Ellingsod. chapter no 27 Stroke, Editors: Joseph T. Dipiro, gary c.yee, L.michael posey, Stuart T.Haines, Thomas D. Nolin, Vicki L. Ellingrod , Pharmacotherapy a pathophysiologic Approach 11thedition (2011). p.354
Sandhya Gautham, Chhaya Mittal, Alok Ranjan, Gajraj Singh, Association of Diabetic Peripheral Neuropathy with Micronutrients, Journal of Association of Physician of India (2024) may, volume 72 issue 5 p. 65-67.
Chien-Hsing Lee a,b, Yi-Ling Wu c, Jeng-Fu Kuo d, Jung-Fu Chen e, Ming-Chu Chin c, YiJen Hung b,f, Prevalence of diabetic macrovascular complications and related factors from 2005 to 2014 in Taiwan: A nationwide survey, Journal of the Formosan Medical Association (2019 august 29) 118, S96-S102.
Cameron Hurst, Bandit Thinkhamrop, Hoang The Tran, The Association between Hypertension Comorbidity and Microvascular Complications in Type 2 Diabetes Patients: A Nationwide CrossSectional Study in Thailand, Epidemiology Diabetes & Metabolism Journal 2015; 39(5): 395-404.
Alwakeel, Jamal S; Al-Suwaida, Abdulkareem; Isnani, Arthur C.; Al-Harbi, Ali; Alam, Awatif, Concomitant Macro and Microvascular Complications in Diabetic Nephropathy, Saudi Journal of Kidney Diseases and Transplantation May–Jun 2009, 20(3): p 402-409.
Chandy, Anila; Pawar, Basant; John, Mary; Isaac, Rajesh, Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications, Saudi Journal of Kidney Diseases and Transplantation Nov–Dec 2008.19(6): p 924-928.
RP Agrawal, M Ranka, R Beniwal, S Sharma, VP Purohit, DK Kochar, RP Kothari, Prevalence of Micro and Macro Vascular Complications in Type 2 Diabetes and Their Risk factors, S.P. Medical College, Bikaner, Int. J. Diab. Dev. Countries (2004), Vol. 24, p 11-26.
R. Williams, L. Van Gaal & C. Lucioni, Assessing the impact of complications on the costs of Type II diabetes, Springer-Verlag 2002 12 June, Volume 45, pages S13–S17.
Elizabeth Selvin, MPH; Thomas P. Erlinger, MD Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States,2004 American Heart Association, Inc Circulation. 2004; 110:738-743.
Domenico Fedele, MD; Giancarlo Comi, MD; Carlo Coscelli, MD; Domenico Cucinotta, MD; Eva L Feldman, MD; Giovanni Ghirlanda, MD; Douglas A Greene, MD; Paolo Negrin, MD; Fausto Santeusanio, MD;, A Multicenter Study on the Prevalence of Diabetic Neuropathy in Italy , Diabetes Care may 01 1997;20(5):836–843.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.